ADTXAditxt, Inc.

0.0050USD+138.10%Mkt Cap: 4.99M $P/E:

Aditxt, Inc. focuses on discovery and development of biopharmaceutical products. The company develops AditxtScore and FlowSpot that enable individuals to understand, manage, and monitor their immune profiles in order to …